Over recent years, positron emission tomography/computed tomography (PET/CT) imaging using radiolabeled prostate-specific membrane antigen (PSMA) ligands has been proven to be a useful diagnostic modality in patients with biochemical recurrence (BR) for the detection of local recurrence (LR) of PCa after primary therapy. Here, FOLH1 is linked to posterior cortical atrophy.